X hits on this document





15 / 49

Reviewer Brian Hiestand

Employment Ohio State University

Research Grant

Other Research Support

Speakers’ Bureau/Honoraria

Expert Witness None

Ownership Interest

Consultant/Advisory Board

Other None

Biosite Inc.*; Inovise Medical*; Medtronic*; The Medicines Company*

Inovise Medical*



newMentor, a medical writing/editing company that makes frequent use of the ACC/AHA guidelines*

Jim Januzzi

Massachusetts General Hospital

Roche Diagnostics†; Siemens†; Critical Diagnostics*





Roche Diagnostics*; Critcal Diagnostics*


Donna Mancini Frank Peacock

Columbia University Cleveland Clinic Foundation

None None

None None

None None

None None

None None

Celladon† None

None None

Reviewer Disclosures

Weintraub et al

Acute Heart Failure Syndromes


This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “Significant” if (a) the person receives $10 000 or more during any 12 month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “Modest” if it is less than “Significant” under the preceding definition.


  • Significant.


  • 1.

    Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2010 Update: a report from the American Heart Association. Circulation. 2010;121:e46–e215.

  • 2.

    Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report. 2008;1–29.

  • 3.

    Collins SP, Levy PD, Lindsell CJ, Pang PS, Storrow AB, Miller CD, Naftilan AJ, Thohan V, Abraham WT, Hiestand B, Filippatos G, Diercks DB, Hollander J, Nowak R, Peacock WF, Gheorghiade M. The rationale for an acute heart failure syndromes clinical trials network. J Card Fail. 2009;15:467– 474.

  • 4.

    Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557–573.

  • 5.

    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incor- porated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Inter- national Society for Heart and Lung Transplantation. Circulation. 2009; 119:e391– e479.

  • 6.

    Gibbons RJ, Smith S, Antman E; American College of Cardiology; American Heart Association. American College of Cardiology/ American Heart Association clinical practice guidelines: part I: where do they come from? Circulation. 2003;107:2979–2986.

  • 7.

    Cotter G, Felker GM, Adams KF, Milo-Cotter O, O’Connor CM. The pathophysiology of acute heart failure–is it all about fluid accumulation? Am Heart J. 2008;155:9–18.

  • 8.

    Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J; 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008;359:142–151.

  • 9.

    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mor- tality in patients with acute decompensated heart failure requiring intra- venous vasoactive medications: an analysis from the Acute Decom- pensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57–64.

  • 10.

    Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49:1943–1950.

  • 11.

    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB;

OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768–777.

  • 12.

    Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospi- talized with acute heart failure. JAMA. 2006;296:2217–2226.

  • 13.

    Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Chris- tenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie BM, O’Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010;56:343–351.

  • 14.

    ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines. Available at: http:// www.americanheart.org/presenter.jhtml?identifier3039684. Accessed December 26, 2009.

  • 15.

    Kapoor JR, Perazella MA. Diagnostic and therapeutic approach to acute decompensated heart failure. Am J Med. 2007;120:121–127.

  • 16.

    Gheorghiade M, Mebazaa A. The challenge of acute heart failure syn- dromes. Am J Cardiol. 2005;96:86G–89G.

  • 17.

    Nohria A, Mielniczuk LM, Stevenson LW. Evaluation and monitoring of patients with acute heart failure syndromes. Am J Cardiol. 2005;96: 32G– 40G.

  • 18.

    Mebazaa A, Gheorghiade M, Pina IL, Harjola VP, Hollenberg SM, Follath F, Rhodes A, Plaisance P, Roland E, Nieminen M, Komajda M, Parkhomenko A, Masip J, Zannad F, Filippatos G. Practical recommen- dations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med. 2008; 36(suppl):S129 –S139.

  • 19.

    Neuenschwander JF 2nd, Baliga RR. Acute decompensated heart failure. Crit Care Clin. 2007;23:737–758, vi.

  • 20.

    Peacock WF, Soto-Ruiz KM. Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department. Acute Card Care. 2009;11:138–145.

  • 21.

    Collins S, Storrow AB, Kirk JD, Pang PS, Diercks DB, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med. 2008;51:45–57.

  • 22.

    Diercks DB, Peacock WF, Kirk JD, Weber JE. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006;24:319–324.

  • 23.

    Peacock WF. Using the emergency department clinical decision unit for acute decompensated heart failure. Cardiol Clin. 2005;23:569–588, viii.

  • 24.

    Collins SP, Lindsell CJ, Storrow AB, Abraham WT. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med. 2006;47:13–18.

Downloaded from http://circ.ahajournals

.org/ by guest on February 5, 2015

Document info
Document views196
Page views196
Page last viewedSun Jan 22 06:28:30 UTC 2017